Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Kopran Limited
KOPRANKopran Limited, an integrated pharmaceutical company, engages in the manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-acne, anti-infective, anti-thrombotic, antidiabetic, pain management, neuromodular, gastroenterology, and cardiovascular. In addition, the company provides drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, anthelmintics, antipeptic ulcer and gut, and others. Kopran Limited was incorporated in 1958 and is based in Mumbai, India. Address: Parijat House, Mumbai, India, 400018
Analytics
Objectif de Cours de WallStreet
6 251.2 INRRatio C/B
25.0041Rendement du dividende
1.34 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés KOPRAN
Analyse des dividendes KOPRAN
Croissance des dividendes sur 5 ans
–Croissance continue
–Ratio de distribution Moyenne sur 5 ans
29 %Historique des dividendes KOPRAN
Valorisation des titres KOPRAN
financières KOPRAN
Résultats | 2019 | Dynamique |